{
    "Trade/Device Name(s)": [
        "Healgen Propoxyphene Test (Strip, Cassette, Cup, Dip Card)",
        "Healgen Nortriptyline Test (Strip, Cassette, Cup, Dip Card)",
        "Healgen EDDP (Methadone Metabolite) Test (Strip, Cassette, Cup, Dip Card)"
    ],
    "Submitter Information": "Healgen Scientific LLC",
    "510(k) Number": "K151348",
    "Predicate Device Reference 510(k) Number(s)": [
        "K140748"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "LFG",
        "DJR",
        "JXN"
    ],
    "Summary Letter Date": "July 6, 2015",
    "Summary Letter Received Date": "July 9, 2015",
    "Submission Date": "July 6, 2015",
    "Regulation Number(s)": [
        "21 CFR 862.3700",
        "21 CFR 862.3620",
        "21 CFR 862.3910"
    ],
    "Regulation Name(s)": [
        "Propoxyphene Test System",
        "Methadone Test System",
        "Tricyclic antidepressant drugs test system"
    ],
    "Analyte Class(es)": [
        "toxicology"
    ],
    "Analyte(s)": [
        "Propoxyphene",
        "Nortriptyline",
        "EDDP",
        "Norpropoxyphene",
        "Amitriptyline",
        "Clomipramine",
        "Desipramine",
        "Doxepine",
        "Imipramine",
        "Maprotiline",
        "Nordoxepin",
        "Promazine",
        "Promethazine",
        "Trimipramine",
        "Cyclobenzaprine Hydrochloride",
        "Norclomipramine",
        "EMDP",
        "Disopyramide"
    ],
    "Specimen Type(s)": [
        "Human urine"
    ],
    "Specimen Container(s)": [
        ""
    ],
    "Instrument(s)/Platform(s)": [
        ""
    ],
    "Method(s)/Technology(ies)": [
        "Immunochromatographic assay",
        "Lateral flow chromatographic immunoassay",
        "Competitive binding"
    ],
    "Methodologies": [
        "Immunochemistry",
        "Lateral flow assay"
    ],
    "Submission Type(s)": [
        "Strip",
        "Cassette",
        "Cup",
        "Dip Card"
    ],
    "Document Summary": "FDA 510(k) summary for Healgen Propoxyphene, Nortriptyline, and EDDP (Methadone Metabolite) rapid urine immunochromatographic drug tests in multiple formats for qualitative screening.",
    "Indications for Use Summary": "Qualitative screening for Propoxyphene, Nortriptyline, and EDDP (Methadone Metabolite) in human urine; preliminary positive results require confirmation by a more specific method such as GC/MS; intended for prescription and over-the-counter use.",
    "fda_folder": "Toxicology"
}